BioCryst to Present at Upcoming Investor Conference
BioCryst Pharmaceuticals (Nasdaq: BCRX) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The presentation is scheduled for Wednesday, April 9, 2025, at 9:30 a.m. ET.
Investors and interested parties can access both the live audio webcast and a replay of the presentation through the Investors & Media section on BioCryst's official website at http://www.biocryst.com.
BioCryst Pharmaceuticals (Nasdaq: BCRX) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. La presentazione è programmata per mercoledì 9 aprile 2025, alle 9:30 a.m. ET.
Gli investitori e le parti interessate possono accedere sia alla diretta audio in streaming che alla registrazione della presentazione tramite la sezione Investitori & Media sul sito ufficiale di BioCryst all'indirizzo http://www.biocryst.com.
BioCryst Pharmaceuticals (Nasdaq: BCRX) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham. La presentación está programada para miércoles 9 de abril de 2025, a las 9:30 a.m. ET.
Los inversores y partes interesadas pueden acceder tanto a la transmisión de audio en vivo como a la repetición de la presentación a través de la sección de Inversores y Medios en el sitio web oficial de BioCryst en http://www.biocryst.com.
BioCryst Pharmaceuticals (Nasdaq: BCRX)는 제24회 니드햄 연례 가상 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 발표는 2025년 4월 9일 수요일, 오전 9시 30분 ET로 예정되어 있습니다.
투자자 및 관심 있는 분들은 BioCryst의 공식 웹사이트 http://www.biocryst.com의 투자자 및 미디어 섹션을 통해 라이브 오디오 웹캐스트와 발표의 재생을 모두 이용할 수 있습니다.
BioCryst Pharmaceuticals (Nasdaq: BCRX) a annoncé sa prochaine participation à la 24ème Conférence Virtuelle Annuelle de Needham sur la Santé. La présentation est prévue pour mercredi 9 avril 2025, à 9h30 ET.
Les investisseurs et les parties intéressées peuvent accéder à la fois à la diffusion audio en direct et à un enregistrement de la présentation via la section Investisseurs & Médias sur le site officiel de BioCryst à l'adresse http://www.biocryst.com.
BioCryst Pharmaceuticals (Nasdaq: BCRX) hat seine bevorstehende Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt. Die Präsentation ist für Mittwoch, den 9. April 2025, um 9:30 Uhr ET angesetzt.
Investoren und Interessierte können sowohl auf das Live-Audio-Webcast als auch auf die Wiederholung der Präsentation über den Bereich Investoren & Medien auf der offiziellen Website von BioCryst unter http://www.biocryst.com zugreifen.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a.m. ET.
Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com
FAQ
When is BioCryst (BCRX) presenting at the Needham Healthcare Conference 2025?
How can investors access BioCryst's (BCRX) Needham Conference presentation?
Which investor conference is BioCryst (BCRX) attending in April 2025?
Is BioCryst's (BCRX) Needham Conference presentation virtual or in-person?
